Filing Details

Accession Number:
0001181431-14-031720
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-09-10 17:33:34
Reporting Period:
2014-09-08
Filing Date:
2014-09-10
Accepted Time:
2014-09-10 17:33:34
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1567514 Intra-Cellular Therapies Inc. ITCI Pharmaceutical Preparations (2834) 364742850
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1585697 J. Lawrence Hineline C/O Intra-Cellular Therapies, Inc.
3960 Broadway
New York NY 10032
Vp Of Finance Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-09-08 300 $0.50 50,300 No 4 M Direct
Common Stock Disposition 2014-09-08 300 $15.00 50,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2014-09-08 300 $0.00 300 $0.50
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
37,200 2014-12-19 No 4 M Direct
Footnotes
  1. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2014.
  2. All shares underyling this option have vested.